Quest Diagnostics' stock (DGX), which I first wrote about on June 25, 2009 at a price of $55.89, has risen and fallen in roller-coaster fashion lately, with technical indicator violations, but the business model still looks attractive. Here's why. Without question, Quest would benefit from health care reform at the federal level, if it occurs. Congressional Democrats were poised on Friday, March 12 to begin the reconciliation process for a bill that could produce health care reform... or nothing, after 15 months of debate: the bill's fate remains undermined.
The market slipped in and out of a stupor today as traders tried to decide whether the new $980 billion health care reform bill will help or hurt the economy if it passes.
Democrats finally reached 
Unless you've been spending your summer vacation on a tropical beach with no television or internet access, you have seen that the public reception to Congress' proposals for heathcare reform have not exactly been well accepted. I mean, nut jobs showing up to town hall meetings with guns strapped to their legs isn't really the norm.
Could a tax on health care premiums, applied to both businesses and individuals, slow the increase in health insurance premiums? 
The first half of 2009 has whizzed by in what seems like a macroeconomic eye-blink. Wasn't 
AT&T's Meandering Should End Soon
Closing Bell: Does The Market Ever Drop? (TSL, PALM, FDX, NKE, TEVA)
Research In Motion Is in Recovery Mode
